Unraveling the RAGE-NF-κB pathway: implications for modulating inflammation in diabetic neuropathy through photobiomodulation therapy
Lasers in Medical Science · 2024
DOI: 10.1007/s10103-024-04171-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Medical Science, 2024. Verfasst von Nathalia Lopes Ferreira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Anatomia, Laboratório de Neuroanatomia Funcional da Dor, Instituto de Ciências Biomédicas, Universidade de Sao Paulo, 2415 Prof. Line…. Hauptthemen laut MEDLINE: Rats, Wistar, Diabetic Neuropathies, Low-Level Light Therapy, NF-kappa B. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is a primary complication observed in diabetes that severely affects quality of life. Recent evidence suggests that photobiomodulation (PBM) is a promising therapy against painful conditions and nerve damage. However, the effects of PBM on DPN remains mostly unknown. In the present study, we investigated the efficacy of PBM therapy in modulating proinflammatory cytokine expression in both central and peripheral nervous systems of rats with Streptozotocin (STZ)-induced type 1 diabetes. Male Wistar rats were allocated into control (naïve), diabetic (STZ), and treatment (STZ + PBM) groups. A single intraperitoneal (i.p.) injection of STZ (85 mg/kg) was administered for the induction of diabetes. Animals were subjected to 10 treatment sessions, every other day. The results herein presented indicate that PBM treatment diminishes Receptor for Advanced Glycation End-products (RAGE) and Nuclear Factor Kappa B (NF-ϰB) expression in peripheral nervous system and suppresses TNF-α expression in central nervous system tissues. Furthermore, PBM-therapy in diabetic rats also induces increased levels of the anti-inflammatory protein IL-10 in both peripheral and central nervous system. Collectively, our findings demonstrate compelling evidence that PBM-therapy modulates cytokine dynamics and influences RAGE/NF-ϰB axis in a STZ-induced model of type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Anatomia, Laboratório de Neuroanatomia Funcional da Dor, Instituto de Ciências Biomédicas, Universidade de Sao Paulo, 2415 Prof. Lineu Prestes Ave, São Paulo, SP, 05508-000, Brazil.
- Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA.
- Departamento de Biofísica, Laboratório de Neuroendocrinologia do Estresse, Edifício de Ciências Biomédicas, Universidade Federal de São Paulo, 862 Botucatu Street, São Paulo, SP, 04023-062, Brazil.
- Department of Psychology, University of Alabama at Birmingham, 1300 University Boulevard, Birmingham, USA.
- Departamento de Anatomia, Laboratório de Neuroanatomia Funcional da Dor, Instituto de Ciências Biomédicas, Universidade de Sao Paulo, 2415 Prof. Lineu Prestes Ave, São Paulo, SP, 05508-000, Brazil. chacurm@icb.usp.br.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Ferreira, N. L., Rocha, I. R. C., & Chacur, M. (2024). Unraveling the RAGE-NF-κB pathway: implications for modulating inflammation in diabetic neuropathy through photobiomodulation therapy. Lasers in Medical Science. https://doi.org/10.1007/s10103-024-04171-3
Vancouver
Ferreira NL, Rocha IRC, Chacur M. Unraveling the RAGE-NF-κB pathway: implications for modulating inflammation in diabetic neuropathy through photobiomodulation therapy. Lasers in Medical Science. 2024. doi:10.1007/s10103-024-04171-3
BibTeX
@article{Ferreira2024,
author = {Ferreira, Nathalia Lopes and Rocha, Igor Rafael Correia and Chacur, Marucia},
title = {Unraveling the RAGE-NF-κB pathway: implications for modulating inflammation in diabetic neuropathy through photobiomodulation therapy},
journal = {Lasers in Medical Science},
year = {2024},
doi = {10.1007/s10103-024-04171-3}
}
EUVIMED